This HTML5 document contains 60 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q64818661
rdf:type
wikibase:Item
schema:description
clinical trial клінічне випробування ensayu clínicu klinisch onderzoek
rdfs:label
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
skos:prefLabel
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
schema:name
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
p:P1476
wds:Q64818661-5D64C48F-A5C4-440E-A024-D1FC6A5DA476
wdt:P1476
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo
p:P582
wds:Q64818661-024823A2-24DC-46F5-9BE0-13AD86405BDD
wdt:P582
2023-12-31T00:00:00Z
p:P31
wds:Q64818661-D20F6EB2-0C21-49DB-B20E-3E592486FB00
wdt:P31
wd:Q30612
p:P580
wds:Q64818661-CD527F5F-99A3-45E6-8684-B357DDE18B4D
wdt:P580
2017-12-19T00:00:00Z
p:P17
wds:Q64818661-BF84EC90-B4F0-443A-AB85-D87B59854838 wds:Q64818661-C11B48B8-8676-4539-9823-ACB9D11EC775
wdt:P17
wd:Q16 wd:Q30
p:P6153
wds:Q64818661-D2A9F78E-BAF5-4293-8BA7-40EF33D0F77B wds:Q64818661-D3D0FE4A-932A-4721-9E22-973C8059BEB7 wds:Q64818661-D834DA57-C5CB-45BB-A21E-22A7654F2335 wds:Q64818661-EFCAAB5B-00CC-4AF7-980A-A4C574D706D4 wds:Q64818661-3365763B-4A82-4748-96B8-534E2F2D38C8 wds:Q64818661-34359D0B-A10A-4026-9BBF-A55E45C5BD1C wds:Q64818661-1F6FB811-F22E-43B7-86AC-4F7F19838062 wds:Q64818661-ACEB3FE5-FFCF-455A-9A92-B3C12BF8F14C wds:Q64818661-B88664EC-C24A-4A6C-A0E2-DE448D2F67FC wds:Q64818661-BADA603F-B83F-4D2F-8FF0-B8F58BD2AF1D wds:Q64818661-87E3BDED-E336-4789-8219-DCA2CEAE22EE wds:Q64818661-A6207B1F-122C-4C3A-A7ED-7CE8A8D9152E wds:Q64818661-848C6E8B-953C-4C6C-AA9E-B4903E606AC3 wds:Q64818661-84E828CA-5789-4F08-BD12-4B7EED7626D4
wdt:P6153
wd:Q22033932 wd:Q4821833 wd:Q50036553 wd:Q270222 wd:Q2892284 wd:Q6237101 wd:Q30280597 wd:Q1535116 wd:Q4731305 wd:Q501758 wd:Q4796185 wd:Q7016630 wd:Q115376 wd:Q5600442
p:P2899
wds:Q64818661-5508B8AF-D7C0-4999-9523-6360E08D1BDF
wdt:P2899
18
p:P1132
wds:Q64818661-AE4C1B5F-DA7D-4E4E-9BCD-854399D045E6
wdt:P1132
1520
p:P767
wds:Q64818661-9D959FB1-E7C5-41B5-A0E3-6BDD7500443F
wdt:P767
wd:Q212646
p:P8363
wds:Q64818661-9A9025CE-428C-40D9-931A-794D9BB29677
wdt:P8363
wd:Q78089383
p:P3098
wds:Q64818661-59514990-F54E-4BAA-A3A8-4CD2F6B12BA8
wdt:P3098
NCT03281954
p:P6099
wds:Q64818661-24F08B8A-BA22-4E14-B49C-AFA951788E76
wdt:P6099
wd:Q42824827